Lung Cancer Clinical Trial

Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites

Summary

This study is to help determine the most effective type or combination of treatments to offer patients seeking lung cancer screening who are smokers to help them reduce the number of cigarettes they smoke, or quit smoking. The investigators long term goal is to increase the benefits of lung cancer screening by providing a blue print of best practices for screening sites to deliver tobacco treatment to their patients who are smokers, in a way that does not add burden to screening site staff and increases the chances of patients quitting smoking.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Site Eligibility (as per SC self-report)

& Must be designated as an American College of Radiology (ACR) designated lung cancer screening site

Reports at least one year of lung cancer screening experience
Reports conducting at least 20 new initial screenings per month Site Coordinator (SC) Eligibility (as per SC self-report)
Employed as a full-time Site Coordinator at participating lung cancer screening site Patient Eligibility (as per self-report)
Between the ages of 50-80 years old
Seeking baseline or annual follow-up LDCT lung cancer screening
Have at least a 20 pack-year history of smoking
Currently a smoker, defined as self-reported cigarette smoking (some days, every day) within the past 30 days.
Must be reachable by telephone
Must be English or Spanish speaking due to the study materials being available in only these languages and limited available resources for translation.

Exclusion Criteria:

Patient (as per self-report)

NRT is medically contraindicated (e.g., recent heart attack within the last 2 weeks or, unstable/worsening angina).
Smokers who are receiving other tobacco treatment services or have used cessation medications (NRT, bupropion, varenicline) within the past month.

Study is for people with:

Lung Cancer

Phase:

Phase 4

Estimated Enrollment:

1218

Study ID:

NCT03315910

Recruitment Status:

Recruiting

Sponsor:

Memorial Sloan Kettering Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 17 Locations for this study

See Locations Near You

University of Southern California
Los Angeles California, 90033, United States More Info
Christopher Lee, MD
Contact
323-442-8721
Christopher Lee, MD
Principal Investigator
John Muir Health
Walnut Creek California, 94598, United States More Info
Michaela Straznicka, MD
Contact
925-932-6330
Michaela Straznicka, MD
Principal Investigator
WellStar Health System
LaGrange Georgia, 30240, United States More Info
Salman Fidahussein, MD
Contact
706-880-7222
Rush University Medical Center
Chicago Illinois, 60601, United States More Info
Justin Karush, DO
Contact
312-738-3732
Riverside Healthcare
Kankakee Illinois, 60901, United States More Info
Mary Belford, MD
Contact
815-937-1237
St. Mary Medical Center, Community Healthcare System
Crown Point Indiana, 46307, United States More Info
Peter Tothy, MD
Contact
219-310-2550
MercyOne Des Moines Medical Center (Data Collection Only)
Des Moines Iowa, 50314, United States More Info
Richard Deming, MD
Contact
515-643-8780
Maine Medical Center Cancer Institute
Scarborough Maine, 04074, United States
Henry Ford Hospital (Data collection only)
Detroit Michigan, 48202, United States More Info
Eiran Warner, MD
Contact
517-205-1594
Munson Healthcare
Traverse City Michigan, 49684, United States More Info
Kendra Worden, FNP
Contact
231-392-8400
Montefiore Medical Center (Data Collection Only)
Bronx New York, 10467, United States More Info
Linda B Haramati, MD
Contact
718-920-5250
NYU Winthrop Hospital
Mineola New York, 11501, United States More Info
Jeffrey Schneider, MD
Contact
516-663-9500
Memorial Sloan Kettering Cancer Center
New York New York, 10065, United States More Info
Jamie Ostroff, PhD
Contact
646-888-0041
Yuelin Li, PhD
Contact
646-888-0047
Jamie Ostroff, PhD
Principal Investigator
Weill Cornell Medical Center
New York New York, 10065, United States More Info
Bradley Pua, MD
Contact
212-746-6000
Carolinas Healthcare System Blue Ridge
Morganton North Carolina, 28655, United States More Info
James Davidson, MD
Contact
828-580-4577
Fairfield Medical Center
Lancaster Ohio, 43130, United States More Info
Jarrod T Bruce, MD
Contact
740-689-6833
Legacy Health
Portland Oregon, 97210, United States More Info
Jordan Fein, MD
Contact
503-413-5702
Temple University
Philadelphia Pennsylvania, 19140, United States More Info
Cherie Erkmen, MD
Contact
215-707-9115

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Phase:

Phase 4

Estimated Enrollment:

1218

Study ID:

NCT03315910

Recruitment Status:

Recruiting

Sponsor:


Memorial Sloan Kettering Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider